Uganda Pharmaceutical Sector Baseline Survey: 5. Conclusions and Recommendations

Home page | Help | Clear

English | French

Full TOC

Expand Document

Expand Chapter

Preferences

Printable HTML version

Export document as HTML file Help

Abbreviations


Uganda Pharmaceutical Sector Baseline Survey (HAI, WHO; 2002; 67 pages)
	Foreword
	Acknowledgments
	Abbreviations
	Executive summary
	1. Introduction
		a) Demographic characteristics
		b) Health characteristics
		c) Health policy
		d) Health system structure
		e) The Pharmaceutical Sector
			i) National Drug Policy
			ii) Drug supply system
			iii) Key pharmaceutical indicators
			iv) Pharmaceutical sector surveys
	2. Study Design and Methodology
		2.1 Objectives of the survey
		2.2 Methodology
			a) Level I indicators
			b) List of Level II indicators
			c) List of household survey indicators
			d) Training and Sampling
			e) The survey
			f) Ethical Considerations
	3. Findings
		3.1 Level I: Structures and processes of country pharmaceutical situation
		3.2 Level II: Core indicator results
			a) Summary of the Level II core indicator results
			b) Accessibility to Drugs
			c) Stock-out duration in public health facilities and district warehouses
			d) Percentage of prescribed drugs actually dispensed to patients in public health facilities
			e) Affordability of key drugs in public health facilities and private dispensing drug outlets
			f) Prices of key drugs in public health facilities and private dispensing drug outlets
			g) Quality of drugs
			h) Rational drug use
				i) Number of drugs prescribed per patient contact at public health facilities
				ii) Percentage of patients receiving an antibiotic at public health facilities
				iii) Percentage of patients receiving an injection at public health facilities
				iv) Percentage of prescribed drugs on EDLU in public health facilities
				v) Adequacy of labelling at public health facilities
				vi) Adequacy of patient knowledge of how to take medicines at public health facilities
				vii) Prescribing according to STGs at public health facilities
				viii) Availability of STGs and EDLU at public health facilities
		3.3 Household survey results
	4. Interpretation of Results
	5. Conclusions and Recommendations
		a) Conclusions: Positive aspects and areas for improvement identified
		b) Recommendations Summary
	ANNEXES
		Annex 1: Questionnaire on structures and processes of country pharmaceutical situation (Level I)
		Annex 2: Results of Previous Pharmaceutical Sector Surveys
		Annex 3: Adaptation of survey forms with country specific information for Uganda
		Annex 4: Survey forms
		Survey form 1a: Central/District Warehouse
		Survey form 2a: Central/District Warehouse
		Survey form 3a: Central/District Warehouse: Storage Checklist
		Survey form 1b: Public Health Facility
		Survey form 2b: Public Health Facility
		Survey form 3b: Public Health Facility Storage Checklist
		Survey form 4a: Public Health Facility Pharmacy
		Survey form 4b: Private Pharmacy
		Survey form 5: Private Pharmacy
		Survey form 6: Public Health Facility: Rational Drug Use - Prescribing Indicator Form
		Survey form 7: Public Health Facility Rational Drug Use - Patient Care Form
		Survey form 8: Public Health Facility - Standard Treatment Guidelines/EDL
		Survey form 9: Public Health Facility: Treatment of Diarrhoea, ARI, and Pneumonia
		Survey form 9 (cont.): Public Health Facility: Treatment of Other Tracer Diseases
		Survey form 10: Household

5. Conclusions and Recommendations

Please provide your feedback

Abbreviations

English | French